Organ-specific and tumor-size-dependent responses to sunitinib in clear cell renal cell carcinoma

BACKGROUND: Tyrosine kinase inhibitors (TKIs) have been used as standard therapy for patients with advanced renal cell carcinoma (RCC). However, information on factors predicting response to treatment with TKIs is lacking. This study aimed to assess the association between initial tumor size, involv...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuchiya, Norihiko, Yuasa, Takeshi, Maita, Shinya, Narita, Shintaro, Inoue, Takamitsu, Numakura, Kazuyuki, Saito, Mitsuru, Satoh, Shigeru, Yonese, Junji, Habuchi, Tomonori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975282/
https://www.ncbi.nlm.nih.gov/pubmed/24612599
http://dx.doi.org/10.1186/1471-2490-14-26

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975282/
https://www.ncbi.nlm.nih.gov/pubmed/24612599
http://dx.doi.org/10.1186/1471-2490-14-26

Ejemplares similares